Filing Details
- Accession Number:
- 0001628280-20-014283
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-10-05 16:16:14
- Reporting Period:
- 2020-10-05
- Accepted Time:
- 2020-10-05 16:16:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1127537 | Pulmonx Corp | LUNG | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1222358 | Jr. G Dana Mead | C/O Kleiner Perkins Caufield &Amp; Byers 2750 Sand Hill Road Menlo Park CA 94025 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-10-05 | 1,268,411 | $0.00 | 1,268,411 | No | 4 | C | Indirect | See Footnote |
Common Stock | Acquisiton | 2020-10-05 | 168,223 | $0.00 | 1,436,634 | No | 4 | C | Indirect | See Footnote |
Common Stock | Acquisiton | 2020-10-05 | 87,475 | $0.00 | 1,524,109 | No | 4 | C | Indirect | See Footnote |
Common Stock | Acquisiton | 2020-10-05 | 26,315 | $19.00 | 26,315 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | See Footnote |
No | 4 | C | Indirect | See Footnote |
No | 4 | C | Indirect | See Footnote |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series C-1 Preferred Stock | Disposition | 2020-10-05 | 1,268,411 | $0.00 | 1,268,411 | $0.00 |
Common Stock | Series D-1 Preferred Stock | Disposition | 2020-10-05 | 168,223 | $0.00 | 168,223 | $0.00 |
Common Stock | Series E-1 Preferred Stock | Disposition | 2020-10-05 | 87,475 | $0.00 | 87,475 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect |
Footnotes
- The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date.
- The shares are directly held by Kleiner Perkins Caufield & Byers XIII, LLC ("KPCB XIII"). All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XIII is KPCB XIII Associates, LLC ("XIII Associates"). The voting and dispositive control over the shares is shared by individual managing directors of XIII Associates, none of whom has veto power. Excludes 102,725 shares of Common Stock beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers and held for convenience in the name of "KPCB Holdings, Inc. as nominee," for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such shares. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.